2D and 3D Deep Learning Models for MRI-based Parkinson's Disease Classification: A Comparative Analysis of Convolutional Kolmogorov-Arnold Networks, Convolutional Neural Networks, and Graph Convolutional Networks
Parkinson's Disease (PD) diagnosis remains challenging. This study applies Convolutional Kolmogorov-Arnold Networks (ConvKANs), integrating learnable spline-based activation functions into convolutional layers, for PD classification using structural MRI. The first 3D implementation of ConvKANs...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Parkinson's Disease (PD) diagnosis remains challenging. This study applies
Convolutional Kolmogorov-Arnold Networks (ConvKANs), integrating learnable
spline-based activation functions into convolutional layers, for PD
classification using structural MRI. The first 3D implementation of ConvKANs
for medical imaging is presented, comparing their performance to Convolutional
Neural Networks (CNNs) and Graph Convolutional Networks (GCNs) across three
open-source datasets. Isolated analyses assessed performance within individual
datasets, using cross-validation techniques. Holdout analyses evaluated
cross-dataset generalizability by training models on two datasets and testing
on the third, mirroring real-world clinical scenarios. In isolated analyses, 2D
ConvKANs achieved the highest AUC of 0.99 (95% CI: 0.98-0.99) on the PPMI
dataset, outperforming 2D CNNs (AUC: 0.97, p = 0.0092). 3D models showed
promise, with 3D CNN and 3D ConvKAN reaching an AUC of 0.85 on PPMI. In holdout
analyses, 3D ConvKAN demonstrated superior generalization, achieving an AUC of
0.85 on early-stage PD data. GCNs underperformed in 2D but improved in 3D
implementations. These findings highlight ConvKANs' potential for PD detection,
emphasize the importance of 3D analysis in capturing subtle brain changes, and
underscore cross-dataset generalization challenges. This study advances
AI-assisted PD diagnosis using structural MRI and emphasizes the need for
larger-scale validation. |
---|---|
DOI: | 10.48550/arxiv.2407.17380 |